BioCorRx Inc. (BICX)
USD 0.27
(0.0%)
USD 0.27
(0.0%)
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2023 | 53.17 Thousand USD | -173.91% |
| 2022 | 198.56 Thousand USD | 368.41% |
| 2021 | 42.39 Thousand USD | 58.93% |
| 2020 | 26.67 Thousand USD | -83.18% |
| 2019 | 158.58 Thousand USD | -22.9% |
| 2018 | 205.7 Thousand USD | -38.35% |
| 2017 | 333.66 Thousand USD | -36.61% |
| 2016 | 526.34 Thousand USD | -31.89% |
| 2015 | 772.76 Thousand USD | -18.65% |
| 2014 | 949.96 Thousand USD | 71.23% |
| 2013 | 554.77 Thousand USD | 19.13% |
| 2012 | 465.67 Thousand USD | 25.4% |
| 2011 | 371.34 Thousand USD | 0.0% |
| 2010 | - USD | 0.0% |
| 2009 | - USD | 0.0% |
| 2008 | - USD | 0.0% |
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2024 Q2 | -19.29 Thousand USD | 112.89% |
| 2024 Q1 | -31.38 Thousand USD | 61.26% |
| 2023 FY | -146.76 Thousand USD | -173.91% |
| 2023 Q4 | -81 Thousand USD | -1393.2% |
| 2023 Q3 | 6264.00 USD | -32.35% |
| 2023 Q2 | 9259.00 USD | -70.85% |
| 2023 Q1 | 31.76 Thousand USD | -57.19% |
| 2022 Q1 | -15.55 Thousand USD | -239.11% |
| 2022 FY | 198.56 Thousand USD | 368.41% |
| 2022 Q4 | 74.2 Thousand USD | -19.43% |
| 2022 Q3 | 92.09 Thousand USD | 593.67% |
| 2022 Q2 | 13.27 Thousand USD | 185.36% |
| 2021 Q2 | 13.92 Thousand USD | 46.67% |
| 2021 FY | 42.39 Thousand USD | 58.93% |
| 2021 Q3 | 7795.00 USD | -44.01% |
| 2021 Q4 | 11.18 Thousand USD | 43.45% |
| 2021 Q1 | 9492.00 USD | 241.0% |
| 2020 Q4 | -6732.00 USD | -150.77% |
| 2020 Q3 | 13.25 Thousand USD | 114.37% |
| 2020 Q2 | 6185.00 USD | -55.7% |
| 2020 Q1 | 13.96 Thousand USD | -61.5% |
| 2020 FY | 26.67 Thousand USD | -83.18% |
| 2019 Q4 | 36.25 Thousand USD | 49.42% |
| 2019 Q2 | 35.61 Thousand USD | -42.98% |
| 2019 Q1 | 62.45 Thousand USD | 584.29% |
| 2019 Q3 | 24.26 Thousand USD | -31.86% |
| 2019 FY | 158.58 Thousand USD | -22.9% |
| 2018 Q4 | -12.89 Thousand USD | -122.23% |
| 2018 FY | 205.7 Thousand USD | -38.35% |
| 2018 Q3 | 57.99 Thousand USD | 26.97% |
| 2018 Q2 | 45.68 Thousand USD | -60.25% |
| 2018 Q1 | 114.91 Thousand USD | 192.25% |
| 2017 Q2 | 43.87 Thousand USD | -60.43% |
| 2017 Q1 | 110.87 Thousand USD | 71.25% |
| 2017 Q4 | 39.32 Thousand USD | -71.83% |
| 2017 FY | 333.66 Thousand USD | -36.61% |
| 2017 Q3 | 139.58 Thousand USD | 218.11% |
| 2016 Q4 | 64.74 Thousand USD | -50.16% |
| 2016 Q2 | 141.72 Thousand USD | -25.39% |
| 2016 FY | 526.34 Thousand USD | -31.89% |
| 2016 Q1 | 189.96 Thousand USD | 213.05% |
| 2016 Q3 | 129.91 Thousand USD | -8.34% |
| 2015 Q1 | 263.96 Thousand USD | -13.86% |
| 2015 Q3 | 99.08 Thousand USD | -71.61% |
| 2015 Q2 | 349.03 Thousand USD | 32.23% |
| 2015 FY | 772.76 Thousand USD | -18.65% |
| 2015 Q4 | 60.68 Thousand USD | -38.76% |
| 2014 Q3 | 349.66 Thousand USD | 83.31% |
| 2014 FY | 949.96 Thousand USD | 71.23% |
| 2014 Q1 | 103.12 Thousand USD | -99.99% |
| 2014 Q2 | 190.74 Thousand USD | 84.96% |
| 2014 Q4 | 306.42 Thousand USD | -12.37% |
| 2013 Q3 | 277.41 Thousand USD | -35.44% |
| 2013 Q2 | 429.69 Thousand USD | 39.46% |
| 2013 Q1 | 308.1 Thousand USD | -6.34% |
| 2013 FY | 554.77 Thousand USD | 19.13% |
| 2013 Q4 | 713.78 Million USD | 257203.85% |
| 2012 Q3 | -19.88 Thousand USD | -136.12% |
| 2012 Q2 | 55.04 Thousand USD | -45.8% |
| 2012 FY | 465.67 Thousand USD | 25.4% |
| 2012 Q1 | 101.54 Thousand USD | -72.66% |
| 2012 Q4 | 328.97 Thousand USD | 1754.64% |
| 2011 Q3 | - USD | 0.0% |
| 2011 Q1 | - USD | 0.0% |
| 2011 FY | 371.34 Thousand USD | 0.0% |
| 2011 Q4 | 371.34 Thousand USD | 0.0% |
| 2011 Q2 | - USD | 0.0% |
| 2010 Q4 | - USD | 0.0% |
| 2010 FY | - USD | 0.0% |
| 2010 Q1 | - USD | 0.0% |
| 2010 Q2 | - USD | 0.0% |
| 2010 Q3 | - USD | 0.0% |
| 2009 Q3 | - USD | 0.0% |
| 2009 Q1 | - USD | 0.0% |
| 2009 FY | - USD | 0.0% |
| 2009 Q4 | - USD | 0.0% |
| 2009 Q2 | - USD | 0.0% |
| 2008 Q3 | - USD | 0.0% |
| 2008 Q4 | - USD | 0.0% |
| 2008 Q1 | - USD | 0.0% |
| 2008 FY | - USD | 0.0% |
| 2008 Q2 | - USD | 0.0% |
| Name | Gross Profit | Gross Profit Difference |
|---|---|---|
| The Amacore Group, Inc. | 9.39 Million USD | 99.434% |
| Arem Pacific Corporation | 239.16 Thousand USD | 77.767% |
| Assisted 4 Living, Inc. | 712.32 Thousand USD | 92.535% |
| Bionik Laboratories Corp. | 989.87 Thousand USD | 94.628% |
| Banyan Corp. | 5 Million USD | 98.937% |
| Clearday, Inc. | -6.84 Million USD | 100.776% |
| Dental Patient Care America, Inc. | 3.24 Million USD | 98.361% |
| Quantum Medical Transport, Inc. | 1097.61 USD | -4744.526% |
| Empower Clinics Inc. | 1.96 Million USD | 97.298% |
| First Choice Healthcare Solutions, Inc. | -12.19 Thousand USD | 535.995% |
| Selectis Health, Inc. | 5.4 Million USD | 99.017% |
| Ethema Health Corporation | 4.66 Million USD | 98.861% |
| HealthLynked Corp. | 2.34 Million USD | 97.736% |
| HQDA Elderly Life Network Corp. | - USD | -Infinity% |
| Healthcare Solutions Management Group, Inc. | 6.78 Million USD | 99.216% |
| JRSIS Health Care Corporation | 483.05 Thousand USD | 88.992% |
| Comjoyful International Company | - USD | -Infinity% |
| Medical Facilities Corporation | 143.69 Million USD | 99.963% |
| MedSmart Group Inc. | -19.03 Thousand USD | 379.305% |
| North America Frac Sand, Inc. | 73.25 Thousand USD | 27.413% |
| Nova Leap Health Corp. | 9.76 Million USD | 99.456% |
| Nexteligent Holdings, Inc. | 351.66 Thousand USD | 84.879% |
| PAO Group, Inc. | - USD | -Infinity% |
| Primemd Inc. | 10.5 Million USD | 99.494% |
| Raffles Medical Group Ltd | 239.4 Million USD | 99.978% |
| Ryman Healthcare Limited | 260.65 Million USD | 99.98% |
| Stem Cell Authority, Ltd. | - USD | -Infinity% |
| SETO Holdings, Inc. | - USD | -Infinity% |
| Optima Medical Innovations Corp. | -1.21 Million USD | 104.39% |
| Mycotopia Therapies, Inc. | -61.21 Thousand USD | 186.861% |
| U.S. NeuroSurgical Holdings, Inc. | -20 Thousand USD | 365.87% |
| Veltex Corporation | 694.58 Thousand USD | 92.345% |
| World Financial Holding Group | - USD | -Infinity% |
| Xcelerate Inc. | 294.11 Thousand USD | 81.921% |